Thornberry Nancy
Insider CIK 1797826 · SDGR Director · DNLI Director · VRTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DNLI Denali Therapeutics Inc. | S Sale | 2026-09-02 | 2026-09-04 | 615 | $23.74 | $14.6K | 19,686 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2026-09-02 | 2026-09-04 | 10,824 | $22.85 | $247.3K | 20,301 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2026-09-02 | 2026-09-04 | 615 | $23.74 | $14.6K | 19,686 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2026-09-02 | 2026-09-04 | 10,824 | $22.85 | $247.3K | 20,301 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2026-06-22 | 2026-06-23 | 13,313 | — | $0 | 13,313 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award | 2026-06-22 | 2026-06-23 | 8,141 | — | $0 | 25,388 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2026-06-03 | 2026-06-05 | 19,226 | — | $0 | 19,226 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2026-06-03 | 2026-06-05 | 6,408 | — | $0 | 31,125 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2026-05-01 | 2026-05-05 | 1,433 | — | $0 | 1,433 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2026-05-01 | 2026-05-05 | 398 | — | $0 | 398 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | D To issuer | 2026-05-01 | 2026-05-05 | 398 | — | $0 | 2,109 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2026-05-01 | 2026-05-05 | 472 | — | $0 | 2,507 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 9,341 | — | $0 | 9,341 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award | 2025-06-18 | 2025-06-20 | 5,997 | — | $0 | 17,247 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2025-06-03 | 2025-06-05 | 18,111 | — | $0 | 18,111 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2025-06-03 | 2025-06-05 | 6,037 | — | $0 | 24,717 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2025-05-01 | 2025-05-05 | 1,199 | — | $0 | 1,199 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2025-05-01 | 2025-05-05 | 398 | — | $0 | 2,035 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2024-06-18 | 2024-06-20 | 8,550 | — | $0 | 8,550 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award | 2024-06-18 | 2024-06-20 | 5,000 | — | $0 | 11,250 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2024-05-31 | 2024-06-04 | 17,901 | — | $0 | 17,901 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2024-05-31 | 2024-06-04 | 5,967 | — | $0 | 18,680 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2024-05-01 | 2024-05-03 | 1,571 | — | $0 | 1,571 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2024-05-01 | 2024-05-03 | 501 | — | $0 | 1,637 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2023-12-05 | 2023-12-06 | 1,136 | — | $0 | 1,136 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award | 2023-06-15 | 2023-06-16 | 6,250 | — | $0 | 6,250 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 12,649 | — | $0 | 12,649 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2023-06-01 | 2023-06-05 | 4,216 | — | $0 | 12,713 | SEC↗ |
| SDGR Schrodinger, Inc. | M Exercise deriv | 2023-05-22 | 2023-05-23 | 14,850 | — | $0 | 27,020 | SEC↗ |
| SDGR Schrodinger, Inc. | S Sale | 2023-05-22 | 2023-05-23 | 14,850 | $35.00 | $519.8K | 0 | SEC↗ |
| SDGR Schrodinger, Inc. | M Exercise | 2023-05-22 | 2023-05-23 | 14,850 | $11.52 | $171.1K | 14,850 | SEC↗ |
| SDGR Schrodinger, Inc. | M Exercise deriv | 2022-08-11 | 2022-08-12 | 4,950 | — | $0 | 41,870 | SEC↗ |
| SDGR Schrodinger, Inc. | M Exercise | 2022-08-11 | 2022-08-12 | 4,950 | $11.52 | $57.0K | 4,950 | SEC↗ |
| SDGR Schrodinger, Inc. | S Sale | 2022-08-11 | 2022-08-12 | 4,950 | $35.00 | $173.3K | 0 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2022-06-15 | 2022-06-16 | 14,907 | — | $0 | 14,907 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 17,959 | — | $0 | 17,959 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2022-06-02 | 2022-06-06 | 5,986 | — | $0 | 8,497 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2022-01-08 | 2022-01-11 | 627 | — | $0 | 2,511 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 8,736 | — | $0 | 8,736 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2021-01-08 | 2021-01-12 | 7,535 | — | $0 | 7,535 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2021-01-08 | 2021-01-12 | 2,511 | — | $0 | 2,511 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2020-02-10 | 2020-02-10 | 12,909 | — | $0 | 12,909 | SEC↗ |